- Home
- TLSI vs EPSN Comparison
TLSI vs EPSN Comparison
Compare TLSI & EPSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSI
- EPSN
- Stock Information
- Founded
- TLSI 2010
- EPSN 2005
- Country
- TLSI United States
- EPSN Canada
- Employees
- TLSI N/A
- EPSN N/A
- Industry
- TLSI Medical Specialities
- EPSN Oil & Gas Production
- Sector
- TLSI Health Care
- EPSN Energy
- Exchange
- TLSI Nasdaq
- EPSN Nasdaq
- Market Cap
- TLSI 150.3M
- EPSN 139.0M
- IPO Year
- TLSI N/A
- EPSN N/A
- Fundamental
- Price
- TLSI $4.93
- EPSN $6.61
- Analyst Decision
- TLSI Strong Buy
- EPSN Strong Buy
- Analyst Count
- TLSI 6
- EPSN 1
- Target Price
- TLSI $11.75
- EPSN $7.00
- AVG Volume (30 Days)
- TLSI 33.1K
- EPSN 32.0K
- Earning Date
- TLSI 11-14-2024
- EPSN 11-06-2024
- Dividend Yield
- TLSI N/A
- EPSN 3.81%
- EPS Growth
- TLSI N/A
- EPSN N/A
- EPS
- TLSI N/A
- EPSN 0.24
- Revenue
- TLSI $26,891,000.00
- EPSN $31,145,315.00
- Revenue This Year
- TLSI $60.96
- EPSN N/A
- Revenue Next Year
- TLSI $53.65
- EPSN $15.65
- P/E Ratio
- TLSI N/A
- EPSN $27.52
- Revenue Growth
- TLSI 67.90
- EPSN N/A
- 52 Week Low
- TLSI $3.50
- EPSN $4.70
- 52 Week High
- TLSI $10.42
- EPSN $6.75
- Technical
- Relative Strength Index (RSI)
- TLSI 56.22
- EPSN 64.93
- Support Level
- TLSI $4.53
- EPSN $6.11
- Resistance Level
- TLSI $4.92
- EPSN $6.69
- Average True Range (ATR)
- TLSI 0.29
- EPSN 0.26
- MACD
- TLSI -0.02
- EPSN 0.02
- Stochastic Oscillator
- TLSI 50.63
- EPSN 86.41
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of innovative drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product lines Pressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About EPSN Epsilon Energy Ltd. Common Share
Epsilon Energy Ltd is engaged in the acquisition, development, gathering, and production of natural gas and oil reserves. The operating segments of the company include Upstream segment activities including acquisition, development, and production of natural gas reserves on properties within the United States. The Gas Gathering segment partners with two other companies to operate a natural gas gathering system, and the corporate segment activities include corporate listing and governance functions of the corporation. The company generates revenue from the sale of crude oil and natural gas.